跳至主要内容
临床试验/NCT03202732
NCT03202732已完成不适用

DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes: A Randomised Controlled Trial and Interview Study

Annesofie Lunde Jensen2 个研究点 分布在 1 个国家目标入组 344 人开始时间: 2017年10月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
344
试验地点
2
主要终点
HbA1c

研究概览

简要总结

The aim of this study is to investigate the effect of the use of DiabetesFlex in diabetes care compared to standard care in relation to patient involvement and relevance for specific group of persons with T1DM.

The investigators hypothesize that the use of DiabetesFlex will lead to a higher degree of patient in-volvement, improved glycaemic control and a decrease in total number of consultations compared to standard care. Furthermore, the investigators aim to identify if a specific sub-population within the T1DM population will benefit significantly from the intervention.

详细描述

Diabetes Mellitus (DM) is a chronic condition, and provision of individual and effective diabetes care is a major challenge. The is a lack of evidence on the optimal frequency of attending outpatient clinics for persons with T1DM.

The use of patient-reported outcome (PRO) measures in diabetes care area are limited and none existing in a Danish context. This includes studies, which combine PRO measure with diabetes management, patient involvement and self-management.

The study will generate knowledge and directions for ways to reframe and to optimize the future management of diabetes care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18 years Have had T1DM for more than 1 years Be able to use the Danish-language general website on healthcare www.sundhed.dk Be mentally well functioning Understand and read Danish Access to internet

排除标准

  • 未提供

结局指标

主要结局

HbA1c

时间窗: 15 mounth

Non-inferiority with respect to HbA1c

次要结局

  • Patient Activated Measure (PAM)(15 mounth)
  • "Generic questions concerning patient involvement" is validate by "DEFACTUM"(15 mounth)
  • General health will be assessed by items from the SF-36 questionnaire(15 mounth)
  • Health literacy will be assessed by The Health Literacy Questionnaire (sub scale 6 and 9)(15 mounth)
  • The problem Areas In Diabetes Scale (PAID)(15 mounth)
  • Number and type consultations(15 mounth)
  • Well-being will be assessed by the WHO-5 Well-being Index(15 mounth)
  • Blood pressure(15 mounth)
  • Urine albumine/creatinine ratio(15 mounth)
  • Mortality(15 mounth)

研究者

发起方
Annesofie Lunde Jensen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Annesofie Lunde Jensen

Clinical nursespecialist postdoc

Aarhus University Hospital

研究点 (2)

Loading locations...

相似试验